NCT03741101View on ClinicalTrials.gov

Treatment of NF1-related Plexiform Neurofibroma With Trametinib

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

July 15, 2024

Study Completion Date

December 15, 2024

Conditions
Neurofibromatosis 1ChildNeurofibroma, Plexiform
Interventions
DRUG

Trametinib

treatment

Trial Locations (1)

22241

Skåne University Hospital, Lund

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Region Skane

OTHER